BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 4348219)

  • 1. Transplantation immunity to simian virus 40-transformed cells in tumor-bearing mice. II. Evidence for macrophage participation at the effector level of tumor cell rejection.
    Zarling JM; Tevethia SS
    J Natl Cancer Inst; 1973 Jan; 50(1):149-57. PubMed ID: 4348219
    [No Abstract]   [Full Text] [Related]  

  • 2. Transplantation immunity to simian virus 40-transformed cells in tumor-bearing mice. I. Development of cellular immunity to simian virus 40 tumor-specific transplantation antigens during tumorigenesis by transplanted cells.
    Zarling JM; Tevethia SS
    J Natl Cancer Inst; 1973 Jan; 50(1):137-47. PubMed ID: 4348218
    [No Abstract]   [Full Text] [Related]  

  • 3. Participation of macrophages in tumor immunity.
    Tevethia SS; Zarling JM
    Natl Cancer Inst Monogr; 1972 Dec; 35():279-82. PubMed ID: 4349149
    [No Abstract]   [Full Text] [Related]  

  • 4. Tumor-associated transplantation antigens of myelomas induced in BALB-c mice.
    Williams WH; Krueger RG
    J Natl Cancer Inst; 1972 Dec; 49(6):1613-20. PubMed ID: 4119165
    [No Abstract]   [Full Text] [Related]  

  • 5. Differences in the capacity of simian virus 40 (SV40) tumor antigens on cells, membranes and in soluble form to induce transplantation immunity in hamsters and mice.
    Law LW; Takemoto KK; Rogers MJ; Henriksen O; Ting RC
    Int J Cancer; 1978 Sep; 22(3):315-22. PubMed ID: 212373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological enhancement of tumor growth by syngeneic thymus-derived lymphocytes.
    Umiel T; Trainin N
    Transplantation; 1974 Sep; 18(3):244-50. PubMed ID: 4608685
    [No Abstract]   [Full Text] [Related]  

  • 7. Expression of fetal antigens and tumor-specific antigens in SV40-transformed cells. II. Tumor transplantation studies.
    Ting CC; Rodrigues D; Herberman RB
    Int J Cancer; 1973 Sep; 12(2):519-23. PubMed ID: 4134567
    [No Abstract]   [Full Text] [Related]  

  • 8. Development of tumors as a result of graft-versus-host reaction.
    Cornelius EA
    Exp Hematol; 1973; 1(3):135-49. PubMed ID: 4153858
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro studies on the cellular immune response of tumor-bearing mice to SV40-transformed cells.
    Blasecki JW; Tevethia SS
    J Immunol; 1975 Jan; 114(1 Pt 1):244-9. PubMed ID: 163278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of dose and proliferation of SV40-transformed cells with different oncogenic potentials to the level of tumor immunity.
    Stillström J
    Int J Cancer; 1974 Mar; 13(3):273-85. PubMed ID: 4362607
    [No Abstract]   [Full Text] [Related]  

  • 11. Tumorigenicity and antigenicity of mouse cells infected with Simian virus 40. I. Relationship of growth in vitro and in vivo in immunosuppressed and immunocompetent recipients.
    Wright PW; Smith HS; McCoy J
    J Natl Cancer Inst; 1973 Sep; 51(3):951-9. PubMed ID: 4355223
    [No Abstract]   [Full Text] [Related]  

  • 12. Induction of common transplantation antigen by various isolates of papovavirus SV40 and by virus rescued from transformed cells.
    Tevethia SS; Butel JS
    Intervirology; 1973; 2(3):200-5. PubMed ID: 4366480
    [No Abstract]   [Full Text] [Related]  

  • 13. Host response to tumor-associated fetal antigens.
    Salinas FA; Hanna MG
    J Immunol; 1974 Mar; 112(3):1026-34. PubMed ID: 4359781
    [No Abstract]   [Full Text] [Related]  

  • 14. The immunopathology of SV40-induced transformation.
    Mora PT
    Springer Semin Immunopathol; 1982; 5(1):7-32. PubMed ID: 6314571
    [No Abstract]   [Full Text] [Related]  

  • 15. Antigenic modification of mammalian cells undergoing 'spontaneous' malignant conversion.
    Kieler J
    Ser Haematol; 1972; 5(4):93-122. PubMed ID: 4133765
    [No Abstract]   [Full Text] [Related]  

  • 16. Restoration of specific immunity against SV40 tumor-specific transplantation antigen to lymphoid cells from tumor-bearing mice.
    Blasecki JW; Tevethia SS
    Int J Cancer; 1975 Aug; 16(2):275-83. PubMed ID: 51012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effector and enhancing lymphoid cells in plasmacytoma-bearing mice. II. Dynamic changes during tumor progression.
    Wang WC; Berczi I; Hoffmann EG; Sehon AH
    Int J Cancer; 1980 Apr; 25(4):493-501. PubMed ID: 6246008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcellular distribution of the tumor-specific transplantation antigen of simian virus 40-transformed cells.
    Rogers MJ; Law LW; Appella E
    J Natl Cancer Inst; 1977 Oct; 59(4):1291-5. PubMed ID: 198559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of SV40-tumour immunity by SV40-transformed cells in diffusion chambers.
    Stillström J
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1974 Oct; 82B(5):676-86. PubMed ID: 4372855
    [No Abstract]   [Full Text] [Related]  

  • 20. Cell-mediated immunity to virus-induced tumors: generation of lymphocytes sensitized to specific transplantation antigen in mouse cells infected with papovavirus SV40.
    Tevethia SS; Tevethia MJ
    Prog Med Virol; 1975; 21():103-17. PubMed ID: 174151
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.